Reno reports first West Nile virus case this year
The Washoe District Health Department says a resident younger than 50 has been hospitalized with a milder form of the virus.
Earlier this month, Nevada’s first human case of West Nile this year was reported in Lyon County, and officials reported they were investigating the first “probable” human case of the virus this year in the Las Vegas area.
Twelve human cases were reported in Nevada in 2007.
West Nile is transmitted by mosquito bites, and authorities have encouraged residents to use insect repellent and eliminate areas of standing water.
Most people who are infected have no symptoms or what appears to be a mild flu.
West Nile Virus
The West Nile virus (WNV) was first detected in the Western Hemisphere in 1999 and has since rapidly spread across the North Americcan continent into all 48 continental states, seven Canadian provinces, and throughout Mexico. In addition, WNV activity has been detected in Puerto Rico, the Dominican Republic, Jamaica, Guadeloupe and El Salvador.
According to the U.S. Centers for Disease Control and Prevention (CDC), over 15,000 people in the U.S. have tested positive for WNV infection since 1999, including over 500 deaths. Many more people have likely been infected with WNV, but have experienced mild or no symptoms.
Statistically, a person’s risk of contracting West Nile is low, and less than 1% of those infected develop serious illness from the virus. Those at highest risk for serious illness are the elderly and those with lowered immune systems. However, people of all ages can develop serious illness, so it is important for everyone to protect themselves from mosquito bites to minimize the risk of infection.
Check out Comic Book Journal.
August 30th, 2008 at 12:47 pm
So Reno should know about GenoMed’s WNV treatment!
GenoMed, a genomics-based Disease Management company in St. Louis, has had encouraging results treating West Nile virus encephalitis since 2003.
We’ve had about 80% treatment success rate in people (23 of 29 improved) and horses (8 of 10 survived), and 50% in birds (6 of 12 survived). Our first 8 human WNV patients were published in a peer-reviewed medical journal in 2004 (1). This is sufficient for our treatment to officially exist in both the medical and legal senses.
The earlier our treatment is begun, the better the outcome.
Anybody who wants to download our WNV trial protocol can do so for free at any time by clicking on the “West Nile trial” link on our company’s homepage at http://www.genomed.com.
Dave Moskowitz MD
CEO & Chief Medical Officer
GenoMed, Inc. (Ticker symbol GMED on OTC Pink Sheets)
“The public health company™”
1. Moskowitz DW, Johnson FE. The central role of angiotensin I-converting enzyme in vertebrate pathophysiology. Curr Top Med Chem. 2004;4(13):1433-54. PMID: 15379656 (For PDF file, click on paper #6 at: http://www.genomed.com/index.cfm?action=investor&drill=publications)
August 30th, 2008 at 4:51 pm
[...] neighboring Nevada, the first reported cases has appeared in Reno, and in Texas, The Dallas Morning News is reporting that an East Dallas resident has now joined the [...]
August 31st, 2008 at 10:19 am
Thank you, Dr. David Moskowitz for letting us know about your treatment for West Nile Virus!